BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 31578081)

  • 1. Anti-Inflammatory Effects of HDL (High-Density Lipoprotein) in Macrophages Predominate Over Proinflammatory Effects in Atherosclerotic Plaques.
    Fotakis P; Kothari V; Thomas DG; Westerterp M; Molusky MM; Altin E; Abramowicz S; Wang N; He Y; Heinecke JW; Bornfeldt KE; Tall AR
    Arterioscler Thromb Vasc Biol; 2019 Dec; 39(12):e253-e272. PubMed ID: 31578081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apolipoprotein E-/- Mice Lacking Hemopexin Develop Increased Atherosclerosis via Mechanisms That Include Oxidative Stress and Altered Macrophage Function.
    Mehta NU; Grijalva V; Hama S; Wagner A; Navab M; Fogelman AM; Reddy ST
    Arterioscler Thromb Vasc Biol; 2016 Jun; 36(6):1152-63. PubMed ID: 27079878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toll-Like Receptor 9 Plays a Pivotal Role in Angiotensin II-Induced Atherosclerosis.
    Fukuda D; Nishimoto S; Aini K; Tanaka A; Nishiguchi T; Kim-Kaneyama JR; Lei XF; Masuda K; Naruto T; Tanaka K; Higashikuni Y; Hirata Y; Yagi S; Kusunose K; Yamada H; Soeki T; Imoto I; Akasaka T; Shimabukuro M; Sata M
    J Am Heart Assoc; 2019 Apr; 8(7):e010860. PubMed ID: 30905257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-Density Lipoproteins Exert Pro-inflammatory Effects on Macrophages via Passive Cholesterol Depletion and PKC-NF-κB/STAT1-IRF1 Signaling.
    van der Vorst EPC; Theodorou K; Wu Y; Hoeksema MA; Goossens P; Bursill CA; Aliyev T; Huitema LFA; Tas SW; Wolfs IMJ; Kuijpers MJE; Gijbels MJ; Schalkwijk CG; Koonen DPY; Abdollahi-Roodsaz S; McDaniels K; Wang CC; Leitges M; Lawrence T; Plat J; Van Eck M; Rye KA; Touqui L; de Winther MPJ; Biessen EAL; Donners MMPC
    Cell Metab; 2017 Jan; 25(1):197-207. PubMed ID: 27866837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protease-Activated Receptor-2 Plays a Critical Role in Vascular Inflammation and Atherosclerosis in Apolipoprotein E-Deficient Mice.
    Hara T; Phuong PT; Fukuda D; Yamaguchi K; Murata C; Nishimoto S; Yagi S; Kusunose K; Yamada H; Soeki T; Wakatsuki T; Imoto I; Shimabukuro M; Sata M
    Circulation; 2018 Oct; 138(16):1706-1719. PubMed ID: 29700120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Jnk1 Deficiency in Hematopoietic Cells Suppresses Macrophage Apoptosis and Increases Atherosclerosis in Low-Density Lipoprotein Receptor Null Mice.
    Babaev VR; Yeung M; Erbay E; Ding L; Zhang Y; May JM; Fazio S; Hotamisligil GS; Linton MF
    Arterioscler Thromb Vasc Biol; 2016 Jun; 36(6):1122-31. PubMed ID: 27102962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nrf2 in bone marrow-derived cells positively contributes to the advanced stage of atherosclerotic plaque formation.
    Harada N; Ito K; Hosoya T; Mimura J; Maruyama A; Noguchi N; Yagami K; Morito N; Takahashi S; Maher JM; Yamamoto M; Itoh K
    Free Radic Biol Med; 2012 Dec; 53(12):2256-62. PubMed ID: 23051009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transgenic CGI-58 expression in macrophages alleviates the atherosclerotic lesion development in ApoE knockout mice.
    Xie P; Zeng X; Xiao J; Sun B; Yang D
    Biochim Biophys Acta; 2014 Dec; 1841(12):1683-90. PubMed ID: 25178844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ERV1/ChemR23 Signaling Protects Against Atherosclerosis by Modifying Oxidized Low-Density Lipoprotein Uptake and Phagocytosis in Macrophages.
    Laguna-Fernandez A; Checa A; Carracedo M; Artiach G; Petri MH; Baumgartner R; Forteza MJ; Jiang X; Andonova T; Walker ME; Dalli J; Arnardottir H; Gisterå A; Thul S; Wheelock CE; Paulsson-Berne G; Ketelhuth DFJ; Hansson GK; Bäck M
    Circulation; 2018 Oct; 138(16):1693-1705. PubMed ID: 29739755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrophage expression of peroxisome proliferator-activated receptor-alpha reduces atherosclerosis in low-density lipoprotein receptor-deficient mice.
    Babaev VR; Ishiguro H; Ding L; Yancey PG; Dove DE; Kovacs WJ; Semenkovich CF; Fazio S; Linton MF
    Circulation; 2007 Sep; 116(12):1404-12. PubMed ID: 17724261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of myeloid Fatp1 increases atherosclerotic lesion size in Ldlr
    Zhao L; Cozzo AJ; Johnson AR; Christensen T; Freemerman AJ; Bear JE; Rotty JD; Bennett BJ; Makowski L
    Atherosclerosis; 2017 Nov; 266():182-189. PubMed ID: 29035781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Newly developed reconstituted high-density lipoprotein containing sphingosine-1-phosphate induces endothelial tube formation.
    Matsuo Y; Miura S; Kawamura A; Uehara Y; Rye KA; Saku K
    Atherosclerosis; 2007 Sep; 194(1):159-68. PubMed ID: 17118370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polyoxygenated cholesterol ester hydroperoxide activates TLR4 and SYK dependent signaling in macrophages.
    Choi SH; Yin H; Ravandi A; Armando A; Dumlao D; Kim J; Almazan F; Taylor AM; McNamara CA; Tsimikas S; Dennis EA; Witztum JL; Miller YI
    PLoS One; 2013; 8(12):e83145. PubMed ID: 24376657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Germ-free housing conditions do not affect aortic root and aortic arch lesion size of late atherosclerotic low-density lipoprotein receptor-deficient mice.
    Kiouptsi K; Pontarollo G; Todorov H; Braun J; Jäckel S; Koeck T; Bayer F; Karwot C; Karpi A; Gerber S; Jansen Y; Wild P; Ruf W; Daiber A; Van Der Vorst E; Weber C; Döring Y; Reinhardt C
    Gut Microbes; 2020 Nov; 11(6):1809-1823. PubMed ID: 32579470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of atorvastatin and/or probucol on recovery of atherosclerosis in high-fat-diet-fed apolipoprotein E-deficient mice.
    Guo X; Wang L; Xia X; Wang P; Li X
    Biomed Pharmacother; 2019 Jan; 109():1445-1453. PubMed ID: 30551396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholesterol Efflux Pathways Suppress Inflammasome Activation, NETosis, and Atherogenesis.
    Westerterp M; Fotakis P; Ouimet M; Bochem AE; Zhang H; Molusky MM; Wang W; Abramowicz S; la Bastide-van Gemert S; Wang N; Welch CL; Reilly MP; Stroes ES; Moore KJ; Tall AR
    Circulation; 2018 Aug; 138(9):898-912. PubMed ID: 29588315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apolipoprotein A1 Protects Against Necrotic Core Development in Atherosclerotic Plaques: PDZK1-Dependent High-Density Lipoprotein Suppression of Necroptosis in Macrophages.
    Kluck GEG; Qian AS; Sakarya EH; Quach H; Deng YD; Trigatti BL
    Arterioscler Thromb Vasc Biol; 2023 Jan; 43(1):45-63. PubMed ID: 36353992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apolipoprotein AI) Promotes Atherosclerosis Regression in Diabetic Mice by Suppressing Myelopoiesis and Plaque Inflammation.
    Barrett TJ; Distel E; Murphy AJ; Hu J; Garshick MS; Ogando Y; Liu J; Vaisar T; Heinecke JW; Berger JS; Goldberg IJ; Fisher EA
    Circulation; 2019 Oct; 140(14):1170-1184. PubMed ID: 31567014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SOAT1 deficiency attenuates atherosclerosis by regulating inflammation and cholesterol transportation via HO-1 pathway.
    Wu N; Li RQ; Li L
    Biochem Biophys Res Commun; 2018 Jun; 501(2):343-350. PubMed ID: 29567472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deleting myeloid IL-10 receptor signalling attenuates atherosclerosis in LDLR-/- mice by altering intestinal cholesterol fluxes.
    Stöger JL; Boshuizen MC; Brufau G; Gijbels MJ; Wolfs IM; van der Velden S; Pöttgens CC; Vergouwe MN; Wijnands E; Beckers L; Goossens P; Kerksiek A; Havinga R; Müller W; Lütjohann D; Groen AK; de Winther MP
    Thromb Haemost; 2016 Aug; 116(3):565-77. PubMed ID: 27358035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.